Wayland Additive signed a partnership agreement with HTL Co Japan Ltd, which will see the latter operate as a distribution partner of Wayland Additive NeuBeam metal 3D printers in Japan, South Korea and Taiwan.
HTL Co Japan has extensive experience with a wide range of additive manufacturing (AM) processes, including metal AM, together with an esteemed reputation as a supplier of advanced manufacturing technologies. Wayland Additive has demonstrated significant R&D and commercial success with its NeuBeam metal AM process since its introduction in 2020 and full launch earlier this year. In this regard, the cooperation between the two companies is mutually advantageous in a number of key ways and reflects the growing interest and adoption of metal AM technology for production applications across the industry and across the globe.
Will Richardson, CEO at Wayland commented: “It is a great pleasure to make this announcement today and to welcome HTL Co Japan as a strategic partner for Wayland Additive. HTL Co Japan’s reputation speaks for itself and we are delighted to be working with their team to further promote and demonstrate the key benefits of the NeuBeam process as featured in the Calibur3 system, developed and manufactured by Wayland in the UK. Electron Beam (eBeam) AM technology has long held the potential for production applications, but this potential has been hampered by key limitations that we have overcome with NeuBeam. Moving forward, in partnership with HTL Co Japan, we are looking forward to introducing Calibur3 to a much wider audience.”
Manufacturing on Demand
Wayland’s innovative NeuBeam process has been designed to vastly improve the stability of the traditional eBeam metal AM process through a unique and patented charge neutralization capability. Moreover, the NeuBeam process brings much greater flexibility and significantly greater metallurgy options for the production of metal components.
A.K. Acharya, President of HTL Co Japan Ltd, further commented: “We are very excited to agree this partnership with Wayland Additive and to bring Calibur3 to Japan, South Korea and Taiwan for our customers. We have been very impressed with the advanced capabilities of NeuBeam as well as the Wayland Additive team. The timing of this agreement has been well received and we are introducing Calibur3 in Japan for the first time at the ‘Metal Japan’ trade show event this week. We are ending 2021 strongly and anticipate this will continue into 2022 with Wayland and Calibur3.”
NeuBeam technology has been developed in-house from the ground up by a team of physicists that have worked for many decades with electron beam technology and industrial systems in the semi-conductor industry. The science, combined with extensive expertise and experience has allowed Wayland Additive to develop a very capable and reliable system rather than imitating existing systems or adapting off-the-shelf components and re-purposing them.
Peter Hansford, Business Development Director at Wayland Additive, added: “It is a real pleasure to confirm this partnership between Wayland Additive and HTL Co Japan Ltd. HTL is one of the longest established eBeam resellers globally with a wealth of knowledge and understanding of the market in Japan. I have no doubt that Calibur3, featuring NeuBeam technology, will further enhance the capabilities of their customers for producing metal AM parts.”
You might also like:
Nanoscribe and CELLINK join forces to release Quantum X bio 2PP bioprinter: Building off Nanoscribe’s Quantum X microfabrication platform, this dedicated bioprinter represents the power of bioconvergence for the full spectrum of biological and biomedical applications. Based on Nanoscribe’s engineering excellence, the proprietary additive manufacturing technology is customized and reimagined in collaboration with the expertise of bioprinting experts at CELLINK. The new Quantum X bio brings essential features like temperature control, a sterile environment, and functionalized biomaterials. Transferring Nanoscribe’s submicrometer resolution to biofabrication is the key to effectively accelerating innovation across life science applications like tissue engineering, drug delivery, mechanobiology, microfluidics, and vascularized tissue.
* This article is reprinted from 3D Printing Media Network. If you are involved in infringement, please contact us to delete it.
Author: Victor Anusci
Leave A Comment